[
    [
        {
            "time": "",
            "original_text": "平安证券----生物医药行业2020年报及2021一季度综述：医药行业业绩增速逐季上行，子行业持续分化【行业研究】",
            "features": {
                "keywords": [
                    "生物医药",
                    "2020年报",
                    "2021一季度",
                    "医药行业",
                    "业绩增速",
                    "子行业分化"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "平安证券----生物医药行业2020年报及2021一季度综述：医药行业业绩增速逐季上行，子行业持续分化【行业研究】",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]